1 Min Read
Nov 7 (Reuters) - Shenzhen Hepalink Pharmaceutical Co Ltd
* Says its unit plans to increase investment in Ori Healthcare Fund L.P. by $20 million
Source text in Chinese: bit.ly/2ev9kao
Further company coverage: (Reporting by Hong Kong newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.